Indiana University
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Indiana University sits in the top decile of US sponsors by registered trial count (#38 of 15,742 sponsors by registered trial count).
Indiana University: 890 sponsored US clinical trials, 156 recruiting.
Indiana University sponsors 890 registered US clinical trials on ClinicalTrials.gov, 156 of them currently recruiting, and 561 completed. 104 of these trials are in Phase 3-4 (later-stage) and 126 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alzheimer Disease, with 11 trials.
Top-decile sponsor footprint
Indiana University ranks in the top decile of sponsors by registered trial count (#38 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
561 of 688 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
890 total, page 15 of 18
Pediatric Intensive Care Units (ICUs) at Emory-Children's Center Glycemic Control: The PedETrol Trial
NCT01116752
The Effect of Paricalcitol on Creatinine Filtration, Secretion and Glomerular Filtration Rate
NCT01163162
Pilot Study of Erlotinib for the Treatment of Patients With de Novo Acute Myeloid Leukemia
NCT01174043
Alzheimer's Disease Multiple Intervention Trial
NCT01314950
Using Computers to Assist in the Diagnosis and Treatment of Attention-deficit/Hyperactivity Disorder (ADHD)
NCT01351064
Trusopt and Cosopt; Ocular Perfusion Pressure and Blood Flow: New Long-term Prospective Data
NCT01145898
Calcium and Phosphorus Balance and Calcium Kinetics in Patients With Stage 3/4 Chronic Kidney Disease
NCT01161407
Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry
NCT01116674
Modulation of Human Myocardial Metabolism by GLP-1 Dose Response
NCT01607450
Telephone Assessment and Skill-Building Intervention for Stroke Caregivers
NCT01275495
Technology-Enhanced Quitline Services to Prevent Smoking Relapse
NCT00888992
Gabapentin to Improve Patient Tolerance in Endoscopic Retrograde Cholangiopancreatography (ERCP)
NCT01143766
Lymph Fluid and Blood Collection for Identification of Novel Biomarkers
NCT01075607
D-Cycloserine and Social Skills Training in Autism Spectrum Disorders
NCT01086475
Effect of Fish Oil and Vitamin C on Exercise-Induced Bronchoconstriction and Airway Inflammation in Asthma
NCT01057615
Determine the Effects of Gene Differences and Voriconazole on Enzyme CYP2B6 Activity in the Liver in Healthy Volunteers
NCT01104376
Drug and Talk Therapy for Fibromyalgia
NCT01038323
Does Inspection During Insertion Improve Adenoma Yields During Colonoscopy?
NCT01035775
A Pilot Randomized Trial of Polypectomy Techniques for 4-6 mm Colonic Polyps
NCT04666194
Hernia Repair With or Without Sutures
NCT00905320
Endoscopic Ultrasound (EUS)-Guided Ablation of Pancreatic Cysts
NCT01643460
Positron Emission Tomography-computed Tomography (PET-CT) for Main & Branch Intraductal Papillary Mucinous Neoplasm
NCT00988416
Study of the Effectiveness of a Computer Decision Support System to Improve Physicians' Screening for Autism
NCT01612897
Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer
NCT00975975
Prevalence of Pancreatic Cysts During Routine Endoscopic Ultra Sound
NCT01624363
Identification of Celiac Ganglia
NCT01010360
Microparticles in Pediatric Inflammatory Disease
NCT00979485
Trial of Provider-to-Patient Interactive Voice Response (IVR) Calls to Improve Weight Management in Community Health Centers (CHCs)
NCT01131143
Decisionmaking for Abnormal Uterine Bleeding (AUB)
NCT01721304
Comparing Blood Vessel Endothelial Function in HIV-Infected People and Matched HIV-Uninfected People
NCT00919724
Effects of Etravirine on Endothelial Function in HIV-uninfected Adults: A Pilot Study
NCT00871234
Riluzole in Fragile X Syndrome
NCT00895752
Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the Breast
NCT00857714
Sitagliptin Umbilical Cord Blood Transplant Study
NCT00862719
Pentoxifylline and Combination Antiretroviral Therapy to Improve Blood Vessel Function in HIV-Infected People
NCT00864916
Brain Imaging of Quetiapine Response in Anxious Depression
NCT00982345
Vascular Function, Endothelin, and Inflammation in Pre-diabetic Obesity Versus Lean Healthy Controls
NCT00837590
Study of Aripiprazole in the Treatment of Pervasive Developmental Disorders
NCT00870727
Pharmacological Management of Delirium
NCT00842608
Correlation of Chronic Pancreatitis Pathology Features With Endoscopic Ultrasound (EUS) Criteria
NCT01442441
Evaluating the Effectiveness of Pentoxifylline at Improving Blood Vessel Function in HIV-infected People Not Receiving Antiretroviral Medications
NCT00796822
Study of Biomarkers in Blood & Tissue Samples From Patients With Colorectal Cancer or Polyps & Patients Without Polyps
NCT00898378
Study of Lactulose in Children With Chronic Liver Disease
NCT00811434
A Pilot Trial of Itraconazole Pharmacokinetics in Patients With Metastatic Breast Cancer
NCT00798135
Effects of Short Term, High Dose Atorvastatin Therapy on Periprocedural Myonecrosis and Platelet Inhibition After Percutaneous Coronary Intervention (PCI)
NCT00979940
Effect of Dietary Protein Source on Phosphaturia, PTH and FGF23 in Patients With CKD 3 and 4
NCT00764816
Comparative Effects of Fish Oil Supplementation and a Montelukast on EIB and Airway Inflammation in Asthma
NCT00676468
Memory Training Intervention for Breast Cancer Survivors
NCT01497015
Pilot Study of the Feasibility and Efficacy of Working Memory Training in Children With Cochlear Implants
NCT00763243
A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney Disease
NCT00830037
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 56 |
| Phase 2 | 70 |
| Phase 3 | 28 |
| Phase 4 | 76 |
Therapeutic Areas
What is open in the Indiana University pipeline
156 recruiting of 890 indexed (18% open); 561 completed (63%).
Phase mix: 104 late (III/IV) vs 126 early (I/II) (balanced across stages).
Top condition: Alzheimer Disease (11 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Indiana University: open-pipeline peers nationwide
Peers matched on 890 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Indiana University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 890 trials (± recruiting share)
- University of California, Los Angeles · 897 trials · 18% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Edwards Lifesciences · 18% recruiting · 57 trials
- University of South Florida · 17% recruiting · 252 trials
- VA Office of Research and Development · 17% recruiting · 1,668 trials
- ConvaTec · 18% recruiting · 17 trials
Related
What to do with this Indiana University page
890 registered trials is a research-attention snapshot, not an endorsement of Indiana University or any single study.
- 156 of Indiana University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Alzheimer Disease is the condition Indiana University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alzheimer Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Indiana University pipeline card: 890 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.